{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:19:21Z","timestamp":1794025161783,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanxi Provincial Health Commission's \"Four Batches\" Technology-Driven Medical Innovation Plan","award":["2020XM34"],"award-info":[{"award-number":["2020XM34"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the incremental predictive value of modifying the C-reactive protein-triglyceride-glucose (CTI) index with obesity parameters for incident cardiovascular disease (CVD) across Cardiovascular-Kidney-Metabolic (CKM) syndrome stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the longitudinal CHARLS cohort, Cox proportional hazards was utilized. Predictive increments were assessed using time-dependent Nearest Neighbor Estimation (NNE) AUC with Bootstrap resampling, cNRI, and IDI. Pathophysiological mechanisms were explored via Weighted Quantile Sum (WQS) regression and causal mediation analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After adjusting for demographic and clinical confounders, CTI and its modified indices all maintained robust, independent associations with incident CVD. Specifically, except for CTI-BMI, the new index, which incorporates the obesity index, transforms the dose-response relationship from a complex, nonlinear pattern to a threshold linear association. While increments in overall discrimination (AUC) were marginal, both baseline and cumulative CTI-CVAI significantly improved risk reclassification(cNRI: 0.093\u20130.126, IDI: 0.024\u20130.026,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). The CKM stratification reveals stage-dependent predictive effects, with amplified relative risks in CKM 0\u20132 stages and stronger incremental value for risk reclassification in the CKM 3 stage. WQS confirmed visceral adiposity as the dominant risk driver, and physical frailty was identified as a significant pathophysiological mediator of the observed associations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Incorporating obesity indicators, particularly CVAI, into the CTI framework significantly improves the reclassification of CVD risk in early to moderate CKM stages. However, the lack of significant discriminative (AUC) improvement necessitates a careful clinical trade-off between adopting complex composite metrics and maintaining screening feasibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03197-x","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:54:47Z","timestamp":1778496887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose and its modified indices with cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinyu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"3197_CR1","doi-asserted-by":"crossref","unstructured":"Kim SJ, Mesquita FCP, Hochman-Mendez C: New Biomarkers for Cardiovascular Disease. Tex Heart Inst J 2023, 50(5).","DOI":"10.14503\/THIJ-23-8178"},{"issue":"7","key":"3197_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101692","volume":"48","author":"S Saeed","year":"2023","unstructured":"Saeed S, Khan SU, Khan WU, Abdel-Maksoud MA, Mubarak AS, Aufy M, et al. Genome editing technology: a new frontier for the treatment and prevention of cardiovascular diseases. Curr Probl Cardiol. 2023;48(7):101692.","journal-title":"Curr Probl Cardiol"},{"issue":"11","key":"3197_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","volume":"32","author":"B Chong","year":"2025","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2025;32(11):1001\u201315.","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"3197_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"20","key":"3197_CR5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"25","key":"3197_CR6","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3197_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0\u20133: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):277.","journal-title":"Cardiovasc Diabetol"},{"key":"3197_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fcvm.2020.00088","volume":"7","author":"DS Dhindsa","year":"2020","unstructured":"Dhindsa DS, Sandesara PB, Shapiro MD, Wong ND. The evolving understanding and approach to residual cardiovascular risk management. Front Cardiovasc Med. 2020;7:88.","journal-title":"Front Cardiovasc Med"},{"key":"3197_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol. 2022;13:905266.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3197_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3197_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):296.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3197_CR12","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015\u201325.","journal-title":"J Clin Invest"},{"key":"3197_CR13","unstructured":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 2025, 405(10481):813\u2013838."},{"issue":"Suppl 2","key":"3197_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.16263","volume":"27","author":"M Bl\u00fcher","year":"2025","unstructured":"Bl\u00fcher M. An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes. Diabetes Obes Metab. 2025;27(Suppl 2):3\u201319.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"3197_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14290","volume":"23","author":"S Sarma","year":"2021","unstructured":"Sarma S, Sockalingam S, Dash S. Obesity as a multisystem disease: trends in obesity rates and obesity-related complications. Diabetes Obes Metab. 2021;23(Suppl 1):3\u201316.","journal-title":"Diabetes Obes Metab"},{"key":"3197_CR16","doi-asserted-by":"publisher","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M et al: Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017, 377(1):13-27. https:\/\/doi.org\/10.1056\/NEJMoa1614362","DOI":"10.1056\/NEJMoa1614362"},{"issue":"9","key":"3197_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"3197_CR18","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, et al. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30(9):2395\u20139.","journal-title":"Nat Med"},{"issue":"3","key":"3197_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"3197_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037970","volume":"14","author":"G Huo","year":"2025","unstructured":"Huo G, Zheng J, Cao J, Zhang L, Yao Z, Zeng Y, et al. Association between triglyceride-glucose index and carotid plaque stability in different glycemic status: a single-center retrospective study. J Am Heart Assoc. 2025;14(3):e037970.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3197_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3197_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study. Cardiovasc Diabetol. 2025;24(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3197_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82881-y","volume":"14","author":"L Wu","year":"2024","unstructured":"Wu L, Huang Z. Elevated triglyceride glucose index is associated with advanced cardiovascular kidney metabolic syndrome. Sci Rep. 2024;14(1):31352.","journal-title":"Sci Rep"},{"issue":"1","key":"3197_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02869-4","volume":"24","author":"X Ma","year":"2025","unstructured":"Ma X, Ma X, Wang Y, Qiu G, Zhang C. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):303.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3197_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02945-9","volume":"24","author":"Y Yang","year":"2025","unstructured":"Yang Y, Liu A. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):386.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3197_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-020-00653-3","volume":"19","author":"S Chen","year":"2020","unstructured":"Chen S, Xiao Y, Zhou M, Zhou C, Yu M, Huang B, et al. Comparison of life loss per death attributable to ambient temperature among various development regions: a nationwide study in 364 locations in China. Environ Health. 2020;19(1):98.","journal-title":"Environ Health"},{"issue":"1","key":"3197_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-012-9229-1","volume":"14","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013;14(1):5\u201312.","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"3197_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/er.2007-0006","volume":"28","author":"R Muniyappa","year":"2007","unstructured":"Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007;28(5):463\u201391.","journal-title":"Endocr Rev"},{"issue":"1","key":"3197_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000609","volume":"3","author":"A Nohria","year":"2014","unstructured":"Nohria A, Kinlay S, Buck JS, Redline W, Copeland-Halperin R, Kim S, et al. The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc. 2014;3(1):e000609.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"3197_CR30","doi-asserted-by":"publisher","first-page":"E568","DOI":"10.1152\/ajpendo.00297.2009","volume":"297","author":"MA Potenza","year":"2009","unstructured":"Potenza MA, Addabbo F, Montagnani M. Vascular actions of insulin with implications for endothelial dysfunction. Am J Physiol Endocrinol Metab. 2009;297(3):E568-577.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3197_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphys.2015.00231","volume":"6","author":"G Jia","year":"2015","unstructured":"Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Vascular stiffness in insulin resistance and obesity. Front Physiol. 2015;6:231.","journal-title":"Front Physiol"},{"issue":"6","key":"3197_CR32","doi-asserted-by":"publisher","first-page":"C1355","DOI":"10.1152\/ajpcell.00125.2006","volume":"291","author":"JH Lee","year":"2006","unstructured":"Lee JH, Ragolia L. AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol. 2006;291(6):C1355-1365.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"3197_CR33","doi-asserted-by":"publisher","first-page":"C327","DOI":"10.1152\/ajpcell.00254.2008","volume":"296","author":"JH Lee","year":"2009","unstructured":"Lee JH, Palaia T, Ragolia L. Impaired insulin-mediated vasorelaxation in diabetic Goto\u2013Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol. 2009;296(2):C327-338.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3197_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154358","author":"GP P\u00fcschel","year":"2022","unstructured":"P\u00fcschel GP, Klauder J, Henkel J. Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11154358.","journal-title":"J Clin Med"},{"issue":"3","key":"3197_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548.","journal-title":"J Int Med Res"},{"issue":"1","key":"3197_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, et al. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):313.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3197_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia W, Guo J, Yang H, Sheng X, Wei L, et al. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24(1):316.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3197_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254.","journal-title":"Cardiovasc Diabetol"},{"key":"3197_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep38214","volume":"6","author":"MF Xia","year":"2016","unstructured":"Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.","journal-title":"Sci Rep"},{"issue":"10","key":"3197_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP. Body fat distribution and risk of cardiovascular disease: an update. Circ. 2012;126(10):1301\u201313.","journal-title":"Circ"},{"issue":"1","key":"3197_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02836-8","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang B, Huang X, Wang Z, Wang J, Lan H, et al. Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity? Lipids Health Dis. 2025;25(1):33.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3197_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02972-6","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang C, He S, Xie G, Zhang S, Xiong Z, Lu H, et al. Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China. Cardiovasc Diabetol. 2025;24(1):431.","journal-title":"Cardiovasc Diabetol"},{"issue":"7640","key":"3197_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"21","key":"3197_CR44","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circ. 2021;143(21):e984\u20131010.","journal-title":"Circ"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03197-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:50:17Z","timestamp":1783050617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03197-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3197"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03197-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHARLS protocol was approved by the Ethical Review Committee of Peking University (IRB: 00001052\u201311015). All participants provided written informed consent prior to enrollment. This study strictly adhered to the ethical principles outlined in the Declaration of Helsinki, and the reporting of results complied with the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data used in this study were obtained from CHARLS and the relevant data complies with publishing requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}